SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Reata Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – RETA

If you are a shareholder who purchased Reata securities, and/or sold Reata put options, during the Class Period, you have until February 18, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.